K. Braun

Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.

M. Kassack, G. Lambrecht, M. Ganso, 2002, Current pharmaceutical design.

The novel heteromeric bivalent ligand SB9 potently antagonizes P2Y(1) receptor-mediated responses.

H. Bäumert, G. Spatz-Kümbel, E. Mutschler, 2000, Journal of the autonomic nervous system.

Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.

M. Kassack, G. Lambrecht, M. Ganso, 2004, European journal of medicinal chemistry.

NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors

G. Schmalzing, M. Kassack, G. Lambrecht, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist

G. Schmalzing, M. Kassack, G. Lambrecht, 2005, Neuropharmacology.

Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.

M. Kassack, G. Lambrecht, M. Ganso, 2004, European journal of medicinal chemistry.